Vaxcyte, Inc. Common Stock (NASDAQ: PCVX) last traded at $70.65, down 1.02% on the session. The quote above updates while this page is open; the figures below are drawn from Vaxcyte, Inc. Common Stock’s own filings and are restated only when a new one is published.
Vaxcyte, Inc. Common Stock trades on NASDAQ under the ticker PCVX. Its market capitalisation is $10.51 billion.
Valuation measures for Vaxcyte, Inc. Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $10.51B |
|---|---|
| Enterprise value | $10.71B |
| Price / book | 3.81 |
| Beta | 1.11 |
Trailing-twelve-month figures tagged in Vaxcyte, Inc. Common Stock's XBRL filings with the SEC.
| Net income (TTM) |
|---|
| -$1.06B |
| EPS (TTM) | -$7.64 |
|---|
| Return on equity | -38.59% |
|---|
| Cash | $183.19M |
|---|
Range and volume for PCVX over the past 52 weeks.
| 52-week high | $90.75 |
|---|---|
| 52-week low | $39.87 |
| Volume | 2.43M |
| Average volume | 1.77M |
| Previous close | $71.38 |
Dividend history for Vaxcyte, Inc. Common Stock over the trailing twelve months.
| Dividend yield | 0.00% |
|---|---|
| Dividend per share (TTM) | $0.00 |
Invest a chosen dollar amount in Vaxcyte, Inc. Common Stock with fractional shares.
Start investingCreate an account
Investing involves risk, including possible loss of principal. Nothing here is investment advice or a recommendation to buy or sell PCVX.
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.